BioSpace News Archive

Stryker (NYSE: SYK), one of the world’s leading medical technology companies, announced that its Pangea Systems including Femur, Fibula, Tibia, Humerus and Utility have received 510k clearance from the U.S. Food & Drug Administration.

HepaTx, a preclinical-stage biotechnology company developing cell therapies for liver disease, is proud to announce the addition of Dr. Avnesh Thakor

Aerami Therapeutics (“Aerami”), a clinical stage biopharmaceutical company dedicated to breathing life into the treatment of serious and rare cardiopulmonary diseases, today announced the presentation of results from the randomized double-blind, placebo-controlled Phase 1 clinical trial (NCT04903730) of AER-901 at the 2023 European Respiratory Society (ERS) International Congress.

Northwest Biotherapeutics announces that Dr. Linda Liau, MD, PhD, MBA has joined the Company’s Scientific Advisory Board.

Florida Cancer Specialists & Research Institute, LLC is pleased to announce that Board-certified hematologist and medical oncologist Raphael Bosse, MD, PhD has joined the statewide practice.

GoodCap Pharmaceuticals Inc. (“GoodCap” or the “Company”), a leading biopharmaceutical company focused on discovering and developing novel anti-inflammatory treatments for mood-disorders

The American College of Cardiology, through a strategic collaboration with Amgen and Esperion, is launching a new quality improvement campaign, “Driving Urgency in LDL Screening,” to increase the rate of diagnostic LDL screening in patients without a prior cardiac event as well as those with known cardiovascular disease to help clinicians identify those who need treatment in accordance with medical guidelines.

Health Canada has authorized the use of the Moderna SPIKEVAX™ COVID-19 vaccine targeting the Omicron XBB.1.5 subvariant for people six months of age and older.

The U.S. Food and Drug Administration has issued warning letters to eight companies for manufacturing or marketing unapproved ophthalmic drug products in violation of federal law.

M-LIFE™ today announced that Eric Rubenstein, MD has been named as new President of its M-Tubulin subsidiary. Ted Moskal, M-Life™